Prudential plc’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Prudential plc’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$567K	Buy	16,800 +700	+4%	+$21K	﹤0.01%	587
2026 Q1	$468K	Buy	16,100 +1,400	+10%	+$40.6K	﹤0.01%	587
2025 Q4	$385K	Sell	14,700 -5,300	-27%	-$136K	﹤0.01%	634
2025 Q3	$472K	Buy	+20,000	New	+$442K	﹤0.01%	616
2024 Q3	–	Sell	-9,400	Closed	-$218K	–	812
2024 Q2	$218K	Sell	9,400 -16,600	-64%	-$389K	﹤0.01%	720
2024 Q1	$626K	Buy	26,000 +3,500	+16%	+$82K	﹤0.01%	572
2023 Q4	$524K	Sell	22,500 -10,600	-32%	-$213K	0.01%	768
2023 Q3	$674K	Buy	33,100 +4,100	+14%	+$92K	0.01%	658
2023 Q2	$674K	Hold	29,000	–	–	0.01%	701
2023 Q1	$665K	Buy	+29,000	New	+$726K	0.01%	690

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prudential plc's IDNA Position: Q2 2026 in Review

Prudential plc increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 4.3% in Q2 2026, buying an estimated $21K and bringing the position to 16,800 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Prudential plc first reported a position in IDNA in Q1 2023 and has held it in 10 quarters since. The position peaked at $674K in Q2 2023. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Prudential plc held 16,800 shares of iShares Genomics Immunology and Healthcare ETF worth $567K as of Q2 2026.
Prudential plc bought 700 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $21K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Prudential plc's portfolio in Q2 2026, its #587 holding.
Prudential plc first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 10 quarters since.
Prudential plc's iShares Genomics Immunology and Healthcare ETF position peaked at $674K in Q2 2023.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.